Eight weeks after dosing , the bimagrumab-treated patients increased thigh muscle volume ( right leg +6.5 % compared with placebo , p = 0.024 ; left leg +7.6 % , p = 0.009 ) and lean body mass ( +5.7 % compared with placebo , p = 0.014 ) .